Sabry, Sarah http://orcid.org/0000-0002-0960-5474
El Wakeel, Lamia Mohamed http://orcid.org/0000-0003-0250-1709
Saleh, Ayman http://orcid.org/0000-0001-8069-8581
Ahmed, Marwa Adel http://orcid.org/0000-0002-5193-9523
Funding for this research was provided by:
Ain Shams University
Article History
Accepted: 22 February 2022
First Online: 10 March 2022
Declarations
:
: Sarah Sabry, Lamia Mohamed El Wakeel, Ayman Saleh, and Marwa Adel Ahmed have no conflicts of interest to declare that are relevant to the contents of this article. All authors certify that they are not involved in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
: Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
: This study was performed in line with the principles of the Declaration of Helsinki and was registered at ClinicalTrials.gov (ID: NCT04235569). The study protocol was approved by the Research Ethics Committee for Experimental and Clinical Studies at the Faculty of Pharmacy, ASU [ethics approval number: Ph.D. (No. 51), 8 October 2017].
: Written informed consent was obtained from all participants prior to participation in this study.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: All authors contributed to the study’s conception and design. Material preparation and data collection were performed by SS. Analysis was performed by SS, LMEW, MAA, and AS. The first draft of the manuscript was written by SS and all authors edited and revised previous versions of the manuscript. All authors read and approved the final manuscript.